A recent study by IQVIA, developed using IMRD and powered by Dexter, explores the association between glucagon-like peptide-1 (GLP-1) receptor agonists and hepato-pancreato-biliary diseases in individuals with T2D. This research was presented at ISPOR Europe in November 2025. Population health-based research is vital for identifying effective strategies to tackle healthcare challenges and support patients managing […]